Skip to content

Leibniz Healthtech-Lecture: Anika Grüneboom Opens the Toolbox of Fluorescence Microscopy

Dortmund, 3rd December 2021

Imagine being able to observe the nervous or cardiovascular system from the outside, while it is working. A transparent human being would not only be incredibly exciting, but could certainly also clarify many medical questions about the genesis, early detection or therapy of diseases. After all, biological structures are incredibly complex. They consist of different tissues with various characteristics.

Transparency is Prof Dr Anika Grüneboom’s goal. "We need non-destructive and safe methods that allow us to look deep into the body," explained the immunologist and head of the Bioimaging working group at ISAS. The challenges and opportunities of these methods were the topic of the HealthTech Lecture "The Fluorescence Microscopy Toolbox - Building Bridges to Immunology" of the Leibniz Research Alliance “Leibniz Health Technologies” on November 22, 2021.

No "one size fits all" in microscopy

There is a lot to discover in Grüneboom's toolbox. To meet the diverse optical challenges of biological structures, the researcher and her team combine different microscopy techniques. "So far, there is no method that covers all scales in biological samples," said the biologist. For example, to understand an infection and the corresponding immune response, it is necessary to look at the process from different perspectives. One of the imaging techniques Grüneboom uses is fluorescence microscopy (see infobox). This form of light microscopy includes light sheet fluorescence microscopy. Here, a laser illuminates only one thin layer of the sample, for example tissue, at a time, without destroying it. The many individual images are later used to create a 3D model of the entire sample on the computer. However, light sheet fluorescence microscopy alone does not provide a "glass-like" result.

HealthTech-Lecture: Der Werkzeugkasten der Fluoreszenzmikroskopie (Prof. Anika Grüneboom, ISAS)

Grüneboom's patented clearing is used worldwide

Since tissue, for example, can absorb, reflect or scatter light, it prevents a deeper insight beyond the surface without chemical treatment. That is why Grüneboom works with a clearing method she has developed. With the help of cinnamic acid ethyl ester, a naturally occurring aromatic substance, she makes her samples transparent before she analyses them under the microscope. Thus, in 2019, the biologist succeeded in discovering a previously unknown anatomical structure: Blood vessels that run through the cortical bone of mice and serve as small "highways" for immune cells of the bone marrow. The unique feature of Grüneboom's technique, which is being used by researchers all over the world: The clearing can be reversed so that samples are not destroyed. In addition, her method is safe for everyday laboratory use, as it works without any toxic, carcinogenic or explosive chemicals.

Transparent human – no science fiction?

With the right "tools" – in this case, Grüneboom’s clearing – light sheet fluorescence microscopy offers enormous opportunities as a method of analysis. In order to better understand immune diseases or thromboses and to be able to diagnose them more quickly in the future, the Bioimaging group is conducting research on samples from mice. In response to a participant's question about human samples, Grüneboom replied: "In principle, my clearing can also be applied to human tissue samples.”

Artificial intelligence revolutionises the analysis

Grüneboom's method is not only relevant for application-oriented basic research. Fluorescence microscopy can also be used to optimise diagnostic procedures. For example, to detect changes in small vascular clusters (glomeruli) in the kidney. Instead of making histological sections of the kidney and measuring them manually, as is usually the case, an algorithm can recognise, count and analyse each of the approximately 15,000 glomeruli in a kidney from the fluorescence microscope images. "Artificial intelligence allows us to get much more precise statistics because we can not only see a section, but the whole organ," Grüneboom said. She is facing the challenge of analysing the enormously large amounts of data that arise with the new ISAS working group AMBIOM (Analysis of Microscopic BIOMedical Images), headed by Dr. Jianxu Chen, which specialises in artificial intelligence.

Anika Grüneboom.

© ISAS

In principle, my clearing can also be applied to human tissue samples.

Prof. Dr. Anika Grüneboom
Leibnitz-Institut für Analytische Wissenschaften – ISAS – e. V.

How does fluorescence work?

Fluorescence describes the property of substances to absorb short-wave light and to emit it at a different wavelength. In the process, the electrons of the molecule are temporarily excited before they fall back to their original energy level. This releases energy that we perceive as light. In order to be able to recognise certain structures with a fluorescence microscope, researchers stain samples with fluorescent dyes that have the above-mentioned properties. Some substances have a natural fluorescence, they are autofluorescent.

(Cheyenne Peters)

About Anika Grüneboom

Prof Dr Anika Grüneboom (35) has been heading the Bioimaging research group at ISAS since 2020 and holds a professorship for 'Experimental Biomedical Imaging' at the University of Duisburg-Essen (UDE). Born in Essen, she completed her biology studies at RWTH Aachen University from 2006 to 2011. For her doctorate (2017), she changed to the University Hospital Essen. Before being appointed professor at the UDE, she had been a group leader at the University Hospital Erlangen since 2017, where she investigated rheumatological and immunological issues using imaging techniques. Grüneboom has received several awards for her research.

Share

Further articles

Laboratory Meets Clinic: Understanding Heart Function with Stem Cells

How can new therapeutic approaches for heart failure be developed more effectively? Stem cell research plays a central role in the HI-FIVE project. In this interview, PD Dr Anna Klinke (Herz- und Diabeteszentrum NRW) talks about her work between the lab and the clinic. She explains how the versatility of stem cells enables heart and vascular cells to be obtained from individual patients' blood and why this is an important step in investigating the specific effects of new active substances.

What are you doing at ISAS, Kevin?

What changes take place in heart muscle cells when a left ventricular assist device is used? ISAS doctoral student Kevin Hau (28) is tackling this question by researching the consequences of heart attacks using various omics analyses.

Kevin Hau is wearing a white coat bearing the ISAS logo. He is standing next to a microscope in a laboratory. In the lower left corner of the image, a computer screen can be seen. Open on the monitor is a microscopic image of reddish tissue.

Copenhagen: Different Molecules, New Perspectives?

Felix Hormann is spending three months conducting research at the University of Copenhagen. In this interview, the ISAS doctoral student discusses the new perspective he has gained on his lipid research and his exciting day-to-day life as a scientist in Denmark.

Felix Hormann is standing at a crossroads. In the background, there is a traffic sign with writing in Danish.

New Perspectives for Heart Failure Therapy

How are new therapeutic approaches being developed to close the gap in the treatment of patients with heart failure? And what knowledge from clinical practice is crucial for this? Prof. Dr Tanja Rudolph provides insights into her daily work as a cardiologist and talks about her role in the translational research project HI-FIVE, and the future of cardiovascular disease therapy.

PODCAST »NACHGEFORSCHT – DIE LIVESCHALTE INS LABOR« Episode 12: Less Is More, at Least When It Comes to the Number of Cells

PhD student Susmita Ghosh talks about her research on neutrophil granulocytes – tiny immune cells that play a role in both defending the body against infections and inflammatory processes. Instead of working with countless cells, the biologist optimises analytical methods to enable meaningful proteome analyses with an extremely small number of cells. Ghosh explains why ‘less is more’ and what this has to do with modern mass spectrometry in episode 12 of the podcast.

What are you doing at ISAS, Nora?

Nora Pauly is writing her doctoral thesis on the consequences of heart attacks at the joint graduate college of Essen University Hospital and ISAS. With the bed-to-bench-to-bed principle, her work in basic research is closely linked to the everyday clinical practice of caring for heart attack patients.

New Framework for Efficient Image Data Analysis in Biomedicine

How can AI be used optimally in bioimaging research? A team of international researchers and scientists led by Dr Jianxu Chen from ISAS has developed a framework designed to make it easier for biomedical scientists to work with data-centric AI. Using the example of vascular segmentation, the authors of the publication in the journal npj imaging now demonstrate the advantages of the new framework.

3 Questions for Susmita Ghosh

How does gut microbiota affect the immune system? Susmita Ghosh conducts research on proteins and immune cells at ISAS. In this interview, the biologist talks about her work and explains how gut flora and the immune system could affect the outcomes of a stroke.

Susmita Ghosh sitzt am ultrasensitiven Massenspektrometer und stellt eine Proben ein.

Gut Flora & Stroke: How Microorganisms Influence Our Immune System

Which factors can activate immune cells after a stroke? This question was investigated by researchers at University Hospital Essen and ISAS. Their work focused on the gut microbiota.